Correction: Hyaluronic acid-ibuprofen conjugation: a novel ototherapeutic approach protecting inner ear cells from inflammation-mediated damage更正:透明质酸-布洛芬缀合物:一种新型耳治疗途径,保护内耳细胞免受炎症介导的损伤Frontiers in PharmacologyIF4.82026-09-220OA
Cannabinoids activate the insulin pathway to modulate mobilization of cholesterol in C. elegansPLOS GENETICSIF3.72022-11-083OAAI
Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization DisordersJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72021-01-018OAAI
A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesisNEURO-ONCOLOGY ADVANCESIF4.12020-12-0315OAAI
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγNATURE COMMUNICATIONSIF15.72019-12-2026OAAI
Modified carbazoles destabilize microtubules and kill glioblastoma multiform cellsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92018-11-0121OAAI
Novel CYP26B1-selective inhibitor increases measures of epidermal barrier function in healthy, darier's, and ichthyotic econstructed human epidermisJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72018-05-010OAAI
Combination of retinaldehyde and hydroxylapatite mimics the effects of all-trans retinoic acid in reconstructed human epidermisJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72018-05-010OAAI
Novel CYP26 inhibitors potentiate the effects of all-trans-retinoic acid on phenotype of normal and Darier disease keratinocytes in reconstructed human epidermisJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72017-05-010OAAI
Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylasesJOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRYIF5.42016-07-1710OAAI
Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82016-05-0118OAAI
Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid HydroxylaseJOURNAL OF MEDICINAL CHEMISTRYIF6.82016-03-1515OAAI
Characterization of Novel Cannabinoid Based T-Type Calcium Channel Blockers with Analgesic EffectsACS CHEMICAL NEUROSCIENCEIF3.92014-11-0540OAAI
Novel di-aryl-substituted isoxazoles act as noncompetitive inhibitors of the system xc- cystine/glutamate exchangerNEUROCHEMISTRY INTERNATIONALIF42014-07-0114PREAI
Mastering tricyclic ring systems for desirable functional cannabinoid activityEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92013-11-0141OAAI
Synthesis of New Quinolinequinone Derivatives and Preliminary Exploration of their Cytotoxic PropertiesJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-05-0127OA
In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7JOURNAL OF PHARMACEUTICAL SCIENCESIF3.82013-02-0114OAAI
Nitroarachidonic acid: Therapeutic potential in vascular inflammation and neurodegenerationFREE RADICAL BIOLOGY AND MEDICINEIF8.22012-09-010PREAI
Neuroinflammation, Hyperphosphorylated Tau, Diffuse Amyloid Plaques, and Down-Regulation of the Cellular Prion Protein in Air Pollution Exposed Children and Young AdultsJOURNAL OF ALZHEIMERS DISEASEIF3.12012-01-12265PREAI